Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study-Reference-Cited by-同舟云学术

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

Published:1998-03 Issue:3 Volume:9 Page:255-260
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Oberhoff C.,Neri B.,Amadori D.,Petry K.U.,Gamucci T.,Rebmann U.,Nowrousian M.R.,Voigtmann R.,Monfardini S.,Armand J.P.,Herrmann R.,Netter-Pinon J.,Tubiana-Mathieu N.,Zwierzina H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/9/3/255/19481671/9-3-255.pdf

Reference23 articles.

1. Pathophysiology of cancer related anemia;Nowrousian,1996

2. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production;Facquin;Blood,1992

3. Toxic effects of cisdichlorodiammineplatinum (II) in man;von Hoff;Cancer Treat Rep,1979

4. Chemotherapy-induced anemia;Miller,1991

5. Cisplatin-associated anemia: An erythropoietin deficiency syndrome;Wood;J Clin Invest,1995

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaemia and pathologic complete response rate according to carboplatin dose in HER2 + breast cancer treated with neoadjuvant TCHP;Cancer Medicine;2022-07-15

2. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20

3. Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy;Meditsinskiy sovet = Medical Council;2022-06-19

4. Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients;PLOS ONE;2017-12-11

5. Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells;PLOS Computational Biology;2016-08-05